Tilray Inks Deal With AMP Making It An Exclusive Marketing Partner For Aphria-Branded Products In Germany

AMP Alternative Medical Products Inc. (Frankfurt: C4TA) (ISIN: CA0318961038) (CSE: XCX) revealed Monday it has been chosen as an exclusive marketing partner for all Aphria branded products imported or cultivated in Germany. Aphria is a medical brand owned by a Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY), and AMP is a pharmaceutical supplier of medical and CBD therapeutic products to German pharmacies based in Erfurt and Berlin. 

The new collaboration is established on a supply and marketing agreement with CC Pharma GmbH, a wholly-owned subsidiary of Tilray.

AMP highlighted the agreement makes a milestone for …

Full story available on Benzinga.com

More Tilray Inks Deal With AMP Making It An Exclusive Marketing Partner For Aphria-Branded Products In Germany